The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,950.00
Bid: 2,952.00
Ask: 2,953.00
Change: 23.00 (0.79%)
Spread: 1.00 (0.034%)
Open: 2,900.00
High: 2,963.00
Low: 2,895.00
Prev. Close: 2,927.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio update and Capital Markets Seminar

23 Sep 2020 07:00

RNS Number : 7923Z
3i Group PLC
23 September 2020
 

 

Press release

23 September 2020

 

3i Group plc

Update on the portfolio and Capital Markets Seminar

 

3i Group plc ("3i" or "the Group") will be holding a Capital Markets Seminar via webcast today, involving presentations on our approach to ESG and responsible investment, as well as on Evernex and SaniSure, two of our recent Private Equity Investments. In addition, Simon Borrows, our Chief Executive, will provide an update on the portfolio, the key elements of which are outlined below. The seminar will start at 14.00 and the joining details are provided at the end of this press release. The presentation materials and a recording of the webcast will also be made available on our website.

We have now completed our September semi-annual portfolio company reviews for Private Equity, Infrastructure and Scandlines, which have reinforced our belief in the resilience and strength of earnings performance in the significant majority of our investments. The automotive sector remains challenged, and public health policy has prolonged the uncertainty for the travel sector. However, we continue to see strong momentum in portfolio companies exposed to medical technology and personal care products and very good recovery in our retail businesses, particularly in online, and of course in Action.

Action's impressive performance has continued with sales, EBITDA and cash generation above expectations for P7 (July), P8 (August) and P9 (September) to date. YTD sales at over €3.7 billion have now recovered to be approximately 8% ahead of last year with strong trading continuing across all geographies. We expect LTM EBITDA to the end of P9 to be approximately €575 million compared to €506 million at September last year and €491 million at the end of P4 this year. Cash generation has continued to be strong with a current cash balance of over €625 million after a €51 million repayment of the RCF. Action has now opened 88 stores in 2020 including its first five stores in the Czech Republic. Initial trading in the Czech Republic has been significantly ahead of expectations.

A live webcast of the seminar will be available at 14.00. To register for the webcast, please visit www.3i.com/investor-relations/capital-markets-presentations/2020.

 

- Ends-

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

Notes to editors:

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDCXSDDGGD
Date   Source Headline
28th May 20215:01 pmRNSDirector/PDMR Shareholding
26th May 20213:16 pmRNSDoc re. 2021 Notice of AGM
19th May 202111:56 amRNSDoc re. 2021 Annual Report and Accounts
13th May 20217:00 amRNSDirectorate Change
13th May 20217:00 amRNSResults for the year to 31 March 2021
30th Apr 20214:09 pmRNSTotal Voting Rights
30th Apr 20214:07 pmRNSDirector/PDMR Shareholding
1st Apr 202110:01 amRNSDirector Declaration
1st Apr 20218:39 amRNSPortfolio Update
31st Mar 20214:50 pmRNSTotal Voting Rights
31st Mar 20214:45 pmRNSDirector/PDMR Shareholding
19th Mar 20213:05 pmRNSDirector Declaration
18th Mar 20217:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 20214:51 pmRNSDirector/PDMR Shareholding
26th Feb 20212:40 pmRNSTotal Voting Rights
26th Feb 20212:37 pmRNSDirector/PDMR Shareholding
8th Feb 20214:57 pmRNSDirector/PDMR Shareholding
29th Jan 20214:30 pmRNSTotal Voting Rights
29th Jan 20214:29 pmRNSDirector/PDMR Shareholding
28th Jan 20217:00 amRNSQ3 Performance update
5th Jan 20213:13 pmRNSTotal Voting Rights
5th Jan 20213:10 pmRNSDirector/PDMR Shareholding
5th Jan 20211:52 pmRNSPortfolio Update
21st Dec 202011:58 amRNSHolding(s) in Company - Replacement
21st Dec 202010:38 amRNSHolding(s) in Company
18th Dec 20209:03 amRNSDirector Declaration
17th Dec 20202:58 pmRNSDirectorate Change
16th Dec 20205:04 pmRNSDirector/PDMR Shareholding
11th Dec 20208:28 amRNSDirectorate Change
10th Dec 20202:21 pmRNSBlock listing Interim Review
30th Nov 20202:20 pmRNSDirector/PDMR Shareholding
30th Nov 20202:20 pmRNSTotal Voting Rights
12th Nov 202011:35 amRNSDoc re. Half Yearly Report 2020
12th Nov 20207:00 amRNSHalf-year Report
30th Oct 20201:56 pmRNSTotal Voting Rights
30th Oct 20201:54 pmRNSDirector/PDMR Shareholding
1st Oct 20201:46 pmRNSPortfolio Update
30th Sep 20205:25 pmRNSTotal Voting Rights
30th Sep 20205:23 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:00 amRNSPortfolio update and Capital Markets Seminar
8th Sep 20202:28 pmRNSDirector/PDMR Shareholding
28th Aug 20202:50 pmRNSTotal Voting Rights
28th Aug 20202:47 pmRNSDirector/PDMR Shareholding
4th Aug 20202:36 pmRNSDirector/PDMR Shareholding
31st Jul 20203:41 pmRNSTotal Voting Rights
31st Jul 20202:40 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSQ1 performance update
16th Jul 20202:22 pmRNSPortfolio Update
1st Jul 20203:00 pmRNSDirector/PDMR Shareholding
30th Jun 20204:17 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.